Erlotinib associated with rosacea-like folliculitis and Malassezia sympodialis [1]

British Journal of Dermatology

Volumn 155, Issue 2, 2006, Pages 477-479

  Cuetara M S ^a   Aguilar, A ^a   Martin, L ^a   Aspiroz, C ^b   Del Palacio, A ^c  

^a HOSPITAL SEVERO OCHOA   (Spain)

^b HOSPITAL ROYO VILLANOVA   (Spain)

^c HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CLINDAMYCIN; ERLOTINIB;

AGED; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CASE REPORT; CLINICAL FEATURE; ERYTHEMA; FOLLICULITIS; HUMAN; KIDNEY CARCINOMA; LETTER; MALASSEZIA; MALASSEZIA SYMPODIALIS; MALE; NEPHRECTOMY; PRIORITY JOURNAL; PRURITUS; RASH; ROSACEA; SKIN BIOPSY;

AGED; ANTINEOPLASTIC AGENTS; DERMATOMYCOSES; DRUG ERUPTIONS; FOLLICULITIS; HUMANS; MALASSEZIA; MALE; QUINAZOLINES; ROSACEA;

EID: 33745904497     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2006.07321.x     Document Type: Letter

References (10)

1. Perez-Soler R, Chachoua A, Hammond LA et al. Determinants of tumor response and survival with erlotinib in patients with non-small-cell lung cancer. J Clin Oncol 2004; 22:3238-47.
2. Guillot J, Guého E, Lesourd M et al. Identification of Malassezia species. A practical approach. J Mycol Med 1996; 6:103-10.
3. Crespo-Erchiga V, Delgado Florencio V. Malassezia species in skin diseases. Curr Opin Infect Dis 2002; 15:133-42.
4. Guého E, Midgley G, Guillot J. The genus Malassezia with description of four new species. Antonie Van Leeuwenhoek 1996; 69:337-55.
5. Sugita T, Tajima M, Ito T et al. Antifungal activities of tacrolimus and azole agents against the eleven currently accepted Malassezia species. J Clin Microbiol 2005; 43:2824-9.
6. Garau M, Relaño MT, Molina L, del Palacio A. Foliculitis en paciente con enfermedad de Hodgkin. Enferm Infecc Microbiol Clin 2003; 21:101-2.
7. Klotz SA, Drutz DJ, Huppert M, Johnson JE. Pityrosporum folliculitis. Its potential for confusion with skin lesions of systemic candidiasis. Arch Intern Med 1982; 142:2126-9.
8. Rosen T, Schell JB, Orengo I. Anti-inflammatory activity of antifungal preparations. Int J Dermatol 1997; 36:788-92.
9. Faergemann F, Bergbrant IM, Dohse M et al. Seborrhoeic dermatitis and Pityrosporum (Malassezia) folliculitis: characterization of inflammatory cells and mediators in the skin by immunohistochemistry. Br J Dermatol 2001; 144:549-56.
10. Hill MK, Goodfield JD, Rodgers FG et al. Skin surface electron microscopy in Pityrosporum folliculilis: the role of follicular occlusion in disease and the response to oral keloconazole. Arch Dermatol 1990; 126:181-4.